Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy

Neuroradiology

Volumn 48, Issue 12, 2006, Pages 887-892

  Ozkan, A ^a   Hakyemez, B ^a   Ozkalemkas, F ^a   Ali, R ^a   Ozkocaman, V ^a   Ozcelik, T ^a   Taskapilioglu, O ^a   Altundal, Y ^a   Tunali, A ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; MRI; Reversible posterior leukoencephalopathy syndrome; Tumor lysis syndrome

Indexed keywords

ALLOPURINOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; PHENYTOIN; VINCRISTINE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLURRED VISION; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HOSPITAL ADMISSION; HUMAN; LEUKOENCEPHALOPATHY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REHYDRATION; REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RISK FACTOR; TONIC CLONIC SEIZURE; TUMOR LYSIS SYNDROME; VOMITING; WEIGHT REDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLINDNESS, CORTICAL; BURKITT LYMPHOMA; COMA; FATAL OUTCOME; FEMALE; HEADACHE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; MAGNETIC RESONANCE IMAGING; SEIZURES; SYNDROME; TUMOR LYSIS SYNDROME;

EID: 33751536932     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-006-0142-8     Document Type: Article

References (35)

1. Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500
2. Stott VL, Hurrell MA, Anderson TJ (2005) Reversible posterior leukoencephalopathy syndrome: A misnomer reviewed. Intern Med J 35:83-90
3. Kitaguchi H, Tomimoto H, Miki Y, et al (2005) A brain stem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 47:652-656
4. Bianco F (2005) Reversible posterior leukoencephalopathy syndrome: A changing concept. Neuroradiology 47:703-704
5. Manfredi M, Beltramello A, Bongiovanni LG, Polo A, Pistioa L, Rizzuto N (1997) Eclamptic encephalopathy: Imaging and pathogenic considerations. Acta Neurol Scand 96:277-282
6. Mukherjee P, McKinstry RC (2001) Reversible posterior leukoencephalopathy syndrome: Evaluation with diffusion-tensor MR imaging. Radiology 219:756-765
7. Ozcakar ZB, Ekim M, Fitoz S, et al (2004) Hypertension induced reversible posterior leukoencephalopathy syndrome: A report of two cases. Eur J Pediatr 163:728-730
8. Yong PF, Hamour SM, Burns A (2003) Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 18:2660-2662
9. Utsumi K, Amemiya S, Lizuka M, Lino Y, Katayama Y (2003) Acute posterior leukoencephalopathy in a patient with nephrotic syndrome. Clin Exp Nephrol 7:63-66
10. Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM (2004) Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 77:72-76
11. Abali H, Eren OO, Dizdar O, et al (2005) Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma. Leuk Lymphoma 46:1825-1828
12. Jarosz JM, Howlett DC, Cox TCS, Bingham JB (1997) Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 39:711-715
13. Kaito E, Terae S, Kobayashi R, Kudo K, Tha KK, Miyasaka K (2005) The role of tumor lysis in reversible posterior leukoencephalopathy syndrome. Pediatr Radiol 35:722-727
14. Greenwood MJ, Dodds AJ, Garrick R, Rodriguez M (2003) Posterior leukoencephalopathy in association with the tumour lysis syndrome in acute lymphoblastic leukemia - a case with clinicopathological correlation. Leuk Lymphoma 44:719-721
15. Honkaniemi J, Kahara V, Dastidor P, et al (2000) Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 42:895-899
16. Bargallo N, Burrel M, Berenguer J, Cofan F, Bunesch L, Mercader M (2000) Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. AJNR Am J Neuroradiol 21:479-484
17. Kahana A, Rowley HA, Weinstein JM (2005) Cortical blindness: Clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome. Ophthalmology 112:7-11
18. Vaughan CJ, Delanthy N (2000) Hypertensive emergencies. Lancet 356:411-417
19. Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OA (1996) Parietal occipital edema in hypertensive encephalopathy: A pathogenic mechanism. Eur Neurol 36:25-28
20. Brubaker LM, Smith JK, Lee YZ, Lin W, Castillo M (2005) Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 26:825-830
21. Henderson RD, Rajah T, Nicol AJ, Read SJ (2003) Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 60:326-328
22. Provenzale JM, Petrella JR, Cruz LC Jr, Wong JC, Engelter S, Barboriak DP (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 22:1455-1461
23. Ito Y, Niwa H, Iida T, et al (1997) Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 49:1174-1175
24. Edvinson L, Owman C, Sjoberg NO (1976) Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 115:377-393
25. Port JD, Beauchamp NJ (1998) Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18:353-367
26. Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R (1996) Reversible encephalopathy with cerebral vasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulin. Neurology 46:250-251
27. Henderson JN, Noctzel MJ, McKinstry RC, White DA, Armstrong M, DeBaun MR (2003) Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 101:414-419
28. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR (1999) Thrombotic thrombocytopenic purpura: Brain CT and MRI findings in 12 patients. Neurology 52:1285-1288
29. Delanty N, Vaughan C, Frucht S, Stubgen P (1997) Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 49:686-689
30. Kastrup O, Maschke M, Wanke I, Diener HC (2002) Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249:1563-1566
31. Utz N, Kinkel B, Hedde JP, Bewermeyer H (2001) MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology 43:1059-1062
32. Ali R, Ozkalemkas F, Ozkan A, et al (2006) Tumour lysis syndrome with acute renal failure during imatinib therapy. Leuk Res (in press). DOI 10.1016/j.leukres.2006.05.005
33. Cairo MS, Bishop M (2004) Tumor lysis syndrome: New therapeutic strategies and classification. Br J Haematol 127:3-11
34. Annemas L, Moeremans K, Lamotte M, et al (2003) Incidence, medical resource utilization and costs of hyperuricemia and tumor lysis syndrome in patients with acute leukemia and non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma 44:77-83
35. Ahn KJ, You WJ, Jeong SL, et al (2004) Atypical manifestations of reversible posterior leukoencephalopathy syndrome: Findings on diffusion imaging and ADC mapping. Neuroradiology 46:978-983